Hostname: page-component-76d6cb85b7-mgxrv Total loading time: 0 Render date: 2026-07-25T12:33:32.045Z Has data issue: false hasContentIssue false

TLR9 Rs352140 polymorphism contributes to a decreased risk of bacterial meningitis: evidence from a meta-analysis

Published online by Cambridge University Press:  04 November 2020

Haiyi Xue
Affiliation:
Department of Critical Care Medicine, Sichuan Cancer Hospital & Institute, Chengdu 610041, People's Republic of China
Huan Peng
Affiliation:
Department of Critical Care Medicine, Sichuan Cancer Hospital & Institute, Chengdu 610041, People's Republic of China
Jiaoming Li
Affiliation:
Department of Neurosurgery, Sichuan Cancer Hospital & Institute, Chengdu 610041, People's Republic of China
Mingming Li
Affiliation:
Department of Neurosurgery, Chengdu Western Hospital, Chengdu 610036, People's Republic of China
Song Lu*
Affiliation:
Department of Critical Care Medicine, Sichuan Cancer Hospital & Institute, Chengdu 610041, People's Republic of China
*
Author for correspondence: Song Lu, E-mail: 3528979168@qq.com
Rights & Permissions [Opens in a new window]

Abstract

Some studies have suggested that the Toll-like receptor 9 polymorphism (TLR9 rs352140) is closely related to the risk of bacterial meningitis (BM), but this is subject to controversy. This study set out to estimate whether the TLR9 rs352140 polymorphism confers an increased risk of BM. Relevant literature databases were searched including PubMed, Embase, the Cochrane Library and China National Knowledge Infrastructure (CNKI) up to August 2020. Seven case-control studies from four publications were enrolled in the present meta-analysis. Odds ratios (OR) and confidence intervals (95% CI) were calculated to estimate associations between BM risk and the target polymorphism. Significant associations identified were allele contrast (A vs. G: OR 0.66, 95% CI 0.59–0.75, P = 0.000), homozygote comparison (AA vs. AG/GG: OR 0.62, 95% CI 0.49–0.78, P = 0.000), heterozygote comparison (A vs. G: OR 0.74, 95% CI 0.61–0.91, P = 0.005), recessive genetic model (AA vs. AG/GG: OR 0.78, 95% CI 0.65–0.93, P = 0.006) and dominant genetic model (AA vs. AG/GG: OR 0.70, 95% CI 0.57–0.85, P = 0.000). The findings indicate that, in contrast to some studies, the TLR9 rs352140 polymorphism is associated with a decreased risk for BM.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press
Figure 0

Fig. 1. Flow diagram for identification of eligible studies for this meta-analysis.

Figure 1

Table 1. Main characteristics of the case-control studies included in meta-analysis

Figure 2

Table 2. Meta-analysis of the TLR9 rs352140 polymorphism with BM risk

Supplementary material: Image

Xue et al. supplementary material

Xue et al. supplementary material

Download Xue et al. supplementary material(Image)
Image 718.6 KB